Browsing Tag
PPD Inc.
1 post
Why Thermo Fisher Scientific (NASDAQ: TMO) is spending US$9.4bn on Clario to dominate clinical-trial analytics
Find out how Thermo Fisher’s US$9.4 billion acquisition of Clario is reshaping the clinical-trial services industry and what it means for investors.